Foresite Capital Opportunity Management V, LLC, 10% Owner at Eikon Therapeutics, Inc. (EIKN), bought 1,396,433 shares at $18.00 ($1000K) on 2026-02-04, disclosed to the SEC on 2026-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,340,878 | $0 | 0.0% |
| 2 | $18.00 | 55,555 | $1000K | 100.0% |
| Total | $0.72 avg | 1,396,433 | $1000K | 100% |
| Filing → |
| PRDS | BUY | 2023-04-06 | $1.2M | — | Filing → |
| THRX | BUY | 2023-01-03 | $1.3M | — | Filing → |
| PRDS | BUY | 2021-12-23 | $3.3M | — | Filing → |